Randomized Pilot Study of Cabergoline, a Dopamine Receptor Agonist: Effects on Body Weight and Glucose Tolerance in Obese Adults

AIM: Dopaminergic hypofunction and hyperprolactinemia have been implicated in the pathogenesis of obesity and glucose intolerance. The aim of this pilot study was to determine the efficacy of cabergoline, a dopamine receptor agonist, on body weight and glucose tolerance in obese non-diabetic persons...

Full description

Saved in:
Bibliographic Details
Main Authors: Gibson, Charlisa D., Karmally, Wahida, McMahon, Donald J., Wardlaw, Sharon L., Korner, Judith
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290696/
https://ncbi.nlm.nih.gov/pubmed/22074059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1463-1326.2011.01534.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items